Works matching IS 2365421X AND DT 2018 AND VI 3 AND IP 1
Results: 15
Futureproofing [<sup>18</sup>F]Fludeoxyglucose manufacture at an Academic Medical Center.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0048-x
- By:
- Publication type:
- Article
Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([<sup>18</sup>F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0046-z
- By:
- Publication type:
- Article
An alternative methodology for the determination of the radiochemical purity of <sup>11</sup>C-methionine.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0053-0
- By:
- Publication type:
- Article
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0045-0
- By:
- Publication type:
- Article
Publisher Correction to EJNMMI Radiopharmacy and Chemistry Volume 1 (2016).
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
A high molar activity <sup>18</sup>F-labeled TAK-875 derivative for PET imaging of pancreatic β-cells.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0051-2
- By:
- Publication type:
- Article
Comparison of fully-automated radiosyntheses of [<sup>11</sup>C]erlotinib for preclinical and clinical use starting from in target produced [<sup>11</sup>C]CO<sub>2</sub> or [<sup>11</sup>C]CH<sub>4</sub>.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0044-1
- By:
- Publication type:
- Article
A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0042-3
- By:
- Publication type:
- Article
19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR’18).
- Published in:
- 2018
- Publication type:
- Proceeding
Preparation and preclinical evaluation of a <sup>68</sup>Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0043-2
- By:
- Publication type:
- Article
Production of novel diagnostic radionuclides in small medical cyclotrons.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0038-z
- By:
- Publication type:
- Article
A new two-strip TLC method for the quality control of technetium-99m mercaptoacetyl-triglycine (<sup>99m</sup>Tc-MAG3).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-018-0040-5
- By:
- Publication type:
- Article
Synthesis of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 0, doi. 10.1186/s41181-018-0039-y
- By:
- Publication type:
- Article
Metabolite profiling with HPLC-ICP-MS as a tool for in vivo characterization of imaging probes.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-017-0037-5
- By:
- Publication type:
- Article
Radiosynthesis and evaluation of an F-labeled silicon containing exendin-4 peptide as a PET probe for imaging insulinoma.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2018, v. 3, n. 1, p. 1, doi. 10.1186/s41181-017-0036-6
- By:
- Publication type:
- Article